Navin Molecular is a future-thinking CDMO, supporting its customers with industry-leading custom development and manufacturing capabilities, across a wide range of chemistries, and with the ability to support a large number of projects each year.

The foundations of the business are to accelerate the development and delivery of small molecules, whilst building long-lasting, open and transparent relationships with its customers. Operating out of world-class facilities at its Dewas, India site, Navin Molecular serves the needs of both global pharmaceutical companies, as well as innovative biotechs, with capacities ranging from grams to multi-ton scales (and to cGMP standards as required).

With extensive expertise in hazardous chemistries (including both direct fluorination and high-pressure chemistries) and a broad range of additional competencies, Navin Molecular prides itself on its ability to provide innovative solutions for complex molecules. The capabilities and capacities of the Dewas site encompass everything from raw materials, through to regulatory starting materials and cGMP intermediates, supporting every stage of a molecules’ clinical development and subsequent commercial supply.

Navin Molecular’s aim is to be the partner of choice for pharmaceutical companies and continues to invest in its infrastructure so as to always provide its customers with the best solutions.

Type of Drugs Manufactured:

Small molecule starting materials and GMP intermediates

CDMO Services:

Process Development; Analytical Development; First-time-scale-up; Commercial scale manufacturing

Number of Manufacturing Facilities:

2

Facilities Locations:

Europe,  South Asia

Regulatory Approvals:

ISO, GMP

Current Capacity: